Cargando…

Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age

Severe alpha-1-antitrypsin (AAT) deficiency (PiZZ) is a risk factor for liver disease, but the prevalence of liver cirrhosis and hepatocellular cancer in PiZZ adults is unknown. The risk of liver disease in adults with moderate AAT deficiency (PiSZ) is also unknown. A cohort of 127 PiZZ, 2 PiZnull,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mostafavi, Behrouz, Diaz, Sandra, Tanash, Hanan A., Piitulainen, Eeva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371441/
https://www.ncbi.nlm.nih.gov/pubmed/28328804
http://dx.doi.org/10.1097/MD.0000000000006180
_version_ 1782518420317667328
author Mostafavi, Behrouz
Diaz, Sandra
Tanash, Hanan A.
Piitulainen, Eeva
author_facet Mostafavi, Behrouz
Diaz, Sandra
Tanash, Hanan A.
Piitulainen, Eeva
author_sort Mostafavi, Behrouz
collection PubMed
description Severe alpha-1-antitrypsin (AAT) deficiency (PiZZ) is a risk factor for liver disease, but the prevalence of liver cirrhosis and hepatocellular cancer in PiZZ adults is unknown. The risk of liver disease in adults with moderate AAT deficiency (PiSZ) is also unknown. A cohort of 127 PiZZ, 2 PiZnull, 54 PiSZ, and 1 PiSnull individuals were identified by the Swedish national neonatal AAT screening program between 1972 and 1974, when all 200,000 newborn infants in Sweden were screened for AAT deficiency. The cohort has been followed up since birth. Our aim was to study liver function and signs of liver disease in this cohort at 37 to 40 years of age in comparison with a matched, random sample of control subjects identified from the population registry. Eighty seven PiZZ, 32 PiSZ, and 92 control subjects (PiMM) answered a questionnaire on medication and alcohol consumption and provided blood samples. Liver stiffness was assessed by Acoustic Radiation Force Impulse (ARFI) elastography in 32 PiZZ, 15 PiSZ, and 51 PiMM subjects. The median of liver function tests and procollagen-III-peptide were within the normal range in all Pi subgroups. However, the PiZZ men had significantly higher plasma bilirubin than the PiMM men (P = 0.018). Plasma ɣ-glutamyl transferase (GGT) was significantly higher in the PiZZ men (P = 0.009) and the PiSZ men (P = 0.021) compared with the PiMM men. The median of liver stiffness was significantly higher in the PiZZ men (P = 0.037) and the PiSZ men (P = 0.032) compared with the PiMM men. The PiZZ women taking medication influencing liver enzymes had significantly higher GGT than the PiMM women on the corresponding treatment (P = 0.023). These AAT-deficient individuals identified by neonatal screening have normal plasma levels of liver function tests, and no clinical signs indicating liver disease at the age of 37 to 40 years. However, bilirubin, GGT, and liver stiffness are significantly higher in PiZZ men than PiMM men.
format Online
Article
Text
id pubmed-5371441
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-53714412017-04-03 Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age Mostafavi, Behrouz Diaz, Sandra Tanash, Hanan A. Piitulainen, Eeva Medicine (Baltimore) 4500 Severe alpha-1-antitrypsin (AAT) deficiency (PiZZ) is a risk factor for liver disease, but the prevalence of liver cirrhosis and hepatocellular cancer in PiZZ adults is unknown. The risk of liver disease in adults with moderate AAT deficiency (PiSZ) is also unknown. A cohort of 127 PiZZ, 2 PiZnull, 54 PiSZ, and 1 PiSnull individuals were identified by the Swedish national neonatal AAT screening program between 1972 and 1974, when all 200,000 newborn infants in Sweden were screened for AAT deficiency. The cohort has been followed up since birth. Our aim was to study liver function and signs of liver disease in this cohort at 37 to 40 years of age in comparison with a matched, random sample of control subjects identified from the population registry. Eighty seven PiZZ, 32 PiSZ, and 92 control subjects (PiMM) answered a questionnaire on medication and alcohol consumption and provided blood samples. Liver stiffness was assessed by Acoustic Radiation Force Impulse (ARFI) elastography in 32 PiZZ, 15 PiSZ, and 51 PiMM subjects. The median of liver function tests and procollagen-III-peptide were within the normal range in all Pi subgroups. However, the PiZZ men had significantly higher plasma bilirubin than the PiMM men (P = 0.018). Plasma ɣ-glutamyl transferase (GGT) was significantly higher in the PiZZ men (P = 0.009) and the PiSZ men (P = 0.021) compared with the PiMM men. The median of liver stiffness was significantly higher in the PiZZ men (P = 0.037) and the PiSZ men (P = 0.032) compared with the PiMM men. The PiZZ women taking medication influencing liver enzymes had significantly higher GGT than the PiMM women on the corresponding treatment (P = 0.023). These AAT-deficient individuals identified by neonatal screening have normal plasma levels of liver function tests, and no clinical signs indicating liver disease at the age of 37 to 40 years. However, bilirubin, GGT, and liver stiffness are significantly higher in PiZZ men than PiMM men. Wolters Kluwer Health 2017-03-24 /pmc/articles/PMC5371441/ /pubmed/28328804 http://dx.doi.org/10.1097/MD.0000000000006180 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 4500
Mostafavi, Behrouz
Diaz, Sandra
Tanash, Hanan A.
Piitulainen, Eeva
Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age
title Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age
title_full Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age
title_fullStr Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age
title_full_unstemmed Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age
title_short Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age
title_sort liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371441/
https://www.ncbi.nlm.nih.gov/pubmed/28328804
http://dx.doi.org/10.1097/MD.0000000000006180
work_keys_str_mv AT mostafavibehrouz liverfunctioninalpha1antitrypsindeficientindividualsat37to40yearsofage
AT diazsandra liverfunctioninalpha1antitrypsindeficientindividualsat37to40yearsofage
AT tanashhanana liverfunctioninalpha1antitrypsindeficientindividualsat37to40yearsofage
AT piitulaineneeva liverfunctioninalpha1antitrypsindeficientindividualsat37to40yearsofage